SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001714899-21-000033
Filing Date
2021-02-26
Accepted
2021-02-26 08:35:47
Documents
104
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K dnli-20201231.htm   iXBRL 10-K 2852456
2 EX-4.3 exhibit43q42020description.htm EX-4.3 30129
3 EX-10.15 ex1015amendeddirectorcompe.htm EX-10.15 44038
4 EX-10.12.4 ex10124amendmentno5todmsa.htm EX-10.12.4 12063
5 EX-10.12.5 ex10125amendmentno3todmsa.htm EX-10.12.5 14790
6 EX-10.12.6 ex10126amendmentno6todmsa.htm EX-10.12.6 44694
7 EX-21.1 exhibit211q42020subsidiari.htm EX-21.1 2528
8 EX-23.1 exhibit231q42020.htm EX-23.1 4264
9 EX-31.1 exhibit311q42020.htm EX-31.1 9981
10 EX-31.2 exhibit312q42020.htm EX-31.2 9980
11 EX-32.1 exhibit321q42020.htm EX-32.1 5685
12 EX-32.2 exhibit322q42020.htm EX-32.2 5792
18 dnli-20201231_g1.jpg GRAPHIC 398863
19 dnli-20201231_g10.jpg GRAPHIC 290849
20 dnli-20201231_g11.jpg GRAPHIC 60195
21 dnli-20201231_g12.jpg GRAPHIC 84926
22 dnli-20201231_g13.jpg GRAPHIC 39657
23 dnli-20201231_g14.jpg GRAPHIC 321331
24 dnli-20201231_g15.jpg GRAPHIC 4216073
25 dnli-20201231_g2.jpg GRAPHIC 1511744
26 dnli-20201231_g3.jpg GRAPHIC 63057
27 dnli-20201231_g4.jpg GRAPHIC 1269661
28 dnli-20201231_g5.jpg GRAPHIC 209302
29 dnli-20201231_g6.jpg GRAPHIC 38168
30 dnli-20201231_g7.jpg GRAPHIC 135038
31 dnli-20201231_g8.jpg GRAPHIC 12651
32 dnli-20201231_g9.jpg GRAPHIC 62945
  Complete submission text file 0001714899-21-000033.txt   31976721

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dnli-20201231.xsd EX-101.SCH 71659
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dnli-20201231_cal.xml EX-101.CAL 98892
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dnli-20201231_def.xml EX-101.DEF 367936
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dnli-20201231_lab.xml EX-101.LAB 845847
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dnli-20201231_pre.xml EX-101.PRE 554452
33 EXTRACTED XBRL INSTANCE DOCUMENT dnli-20201231_htm.xml XML 1751560
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38311 | Film No.: 21683968
SIC: 2836 Biological Products, (No Diagnostic Substances)